SCHEMBL1037103

SCHEMBL1037103

COCCc1cnc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12105173 0.88 HRH3 (0.66)
SCHEMBL8963903 0.79 HRH3 (0.73)
SCHEMBL3136369 0.78
SCHEMBL27501321 0.76 HRH3 (0.58)
SCHEMBL8964986 0.75 HRH3 (0.79)
SCHEMBL8963886 0.75 HRH3 (0.75)
SCHEMBL27680736 0.75 HRH3 (0.50)
SCHEMBL20809601 0.73 HRH3 (0.54)
SCHEMBL3909858 0.73 HRH3 (0.59)
SCHEMBL890317 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086383-A1 SELECT KRAS G12C INHIBITORS AND USES THEREOF 1200 PHARMA LLC (US) 2023-05-19 WO disclosed
CN-105339355-B Novel CYP17 inhibitor/antiandrogen 奥赖恩公司 2018-02-27 CN disclosed
EP-2276464-A2 COMBINATIONS OF ANTIVIRAL AGENTS AND OTHER COMPOUNDS Mallinckrodt Inc. (US) 2011-01-26 EP disclosed
WO-2009129094-A2 COMPOSITIONS CONTAINING ANTIVIRAL COMPOUNDS AND METHODS OF USING THE SAME MALLINCKRODT INC. (US) 2009-10-22 WO disclosed